APA (7th ed.) Citation

Rudin, C. M., Reck, M., Johnson, M. L., Blackhall, F., Hann, C. L., Yang, J. C., . . . Paz-Ares, L. (2023). Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer. Journal of Hematology & Oncology, 16(1), 1. https://doi.org/10.1186/s13045-023-01464-y

Chicago Style (17th ed.) Citation

Rudin, Charles M., et al. "Emerging Therapies Targeting the Delta-like Ligand 3 (DLL3) in Small Cell Lung Cancer." Journal of Hematology & Oncology 16, no. 1 (2023): 1. https://doi.org/10.1186/s13045-023-01464-y.

MLA (9th ed.) Citation

Rudin, Charles M., et al. "Emerging Therapies Targeting the Delta-like Ligand 3 (DLL3) in Small Cell Lung Cancer." Journal of Hematology & Oncology, vol. 16, no. 1, 2023, p. 1, https://doi.org/10.1186/s13045-023-01464-y.